New pill aims to outperform leading heartburn drug in Long-Term protection
NCT ID NCT07313774
Summary
This study tests whether a new drug called linaprazan glurate works better than the approved drug lansoprazole at keeping the esophagus healed in people with chronic acid reflux disease (GERD). About 1,050 adults who have already healed their esophagus in a previous study will take either the new drug or the standard one daily for up to a year. Doctors will use camera exams to check if the healing is maintained and monitor side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERD (GASTROESOPHAGEAL REFLUX DISEASE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.